
Henry Schein remains a dominant global provider of dental and medical practitioner supplies, with recent share price outperformance versus the S&P 500. HSIC delivered strong Q2 results: revenue up 6.7
Henry Schein, Inc. (HSIC) Q2 2026 Earnings Call Transcript